Molina Healthcare Inc (MOH)
Official siteHEALTHCARE • HEALTHCARE PLANS • NYSE
Market Cap: $12.17B
Last updated: Nov 17, 2026 at 4:38 PM ET
Molina Healthcare Inc (MOH) Statistics
Molina Healthcare (MOH) has a market cap of $12.17B and an enterprise value of $11.46B. Its trailing P/E of 110.7x is above its 10-year median of 15.8x. Its return on invested capital of 2.17% compares with a 8.99% median across 9 similar companies.
Total Valuation
Enterprise value is 5.82% below the market cap, as cash exceeds debt.
| Market Cap | $12.17B |
|---|---|
| Enterprise Value | $11.46B |
| Latest price (Nov 17, 2026) | $221.32 |
Key Dates
The next earnings report is expected on Feb 3, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 3, 2027 (expected) |
|---|---|
| Last Earnings Date | Oct 21, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 0.3x and 2.8x. Its year-end P/E ranged from 11.1x to 110.7x from 2016 to 2025.
| P/E Ratio | 110.7x |
|---|---|
| Forward P/E | 41.5x |
| P/S Ratio | 0.3x |
| Forward P/S | 0.3x |
| P/B Ratio | 2.8x |
| P/TBV Ratio | 5.5x |
| P/FCF Ratio | 49.0x |
| P/OCF Ratio | 36.8x |
| PEG Ratio | 11.8 |
Enterprise Valuation
Counting debt and cash, the company is valued at 32.6x EBITDA and 46.0x free cash flow.
| EV / Sales | 0.3x |
|---|---|
| EV / EBITDA | 32.6x |
| EV / EBIT | 66.6x |
| EV / FCF | 46.0x |
Price Statistics
The stock is up 60.91% over 52 weeks and trades 8.64% above its 50-day average.
| Beta (1Y) | -0.05 |
|---|---|
| 52-Week Change | +60.91% |
| 1-Month Change | +5.29% |
| 3-Month Change | +10.02% |
| 6-Month Change | +20.03% |
| 5-Year Change | -30.75% |
| 10-Year Change | +276.36% |
| Total Return (1Y) | +60.91% |
| Total Return (3Y CAGR) | -14.43% |
| Total Return (5Y CAGR) | -6.34% |
| Return vs SPY (1Y) | +45.19% |
| Max Drawdown (1Y) | -39.25% |
| Max Drawdown (3Y) | -70.76% |
| Sharpe Ratio (1Y) | 0.84 |
| Correlation with SPY (1Y) | -0.01 |
| 50-Day Average | $203.72 |
| 200-Day Average | $186.26 |
| 52-Week Range | $121.06 to $244.89 |
| RSI (14 Days) | 57.3 |
| Average Volume (20 Days) | 1.04M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 1.69x current liabilities, and total debt is 0.91x shareholder equity.
| Current Ratio | 1.69x |
|---|---|
| Quick Ratio | 1.69x |
| Debt / Equity | 0.91x |
| Debt / EBITDA | 11.32x |
| Debt / FCF | 15.98x |
| Interest Coverage | 0.81x |
Returns and Efficiency
Return on invested capital is 2.17% over the last 12 months, against a 5-year average of 7.99%.
| Return on Equity (ROE) | -1.16% |
|---|---|
| Return on Assets (ROA) | -0.31% |
| Return on Invested Capital (ROIC) | 2.17% |
| Return on Capital Employed (ROCE) | 2.08% |
| ROE (5Y Average) | 23.10% |
| ROA (5Y Average) | 5.95% |
| ROIC (5Y Average) | 7.99% |
| Asset Turnover | 2.82x |
| Receivables Turnover | 12.90x |
Scores
MOH has an Altman Z-Score of 4.18, in the safe zone above 2.99, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 4.18 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 4 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $44.13B over the last 12 months is down 0.95% from the 12 months before.
| Revenue | $44.13B |
|---|---|
| Revenue Growth (YoY) | -0.95% |
| Gross Profit | $5.56B |
| Operating Income | $172.00M |
| Pretax Income | -$41.00M |
| Net Income | -$48.00M |
| EBITDA | $333.00M |
| EBIT | $172.00M |
| Reported EPS (TTM) | $2.00 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 26.58% of the $15.65B in total assets.
| Cash and Equivalents | $4.48B |
|---|---|
| Total Debt | $3.77B |
| Net Cash | $708.00M |
| Net Cash Per Share | $13.56 |
| Working Capital | $5.12B |
| Shareholder Equity | $4.16B |
| Book Value Per Share | $79.60 |
| Tangible Book Value | $2.08B |
| Tangible Book Per Share | $39.89 |
| Total Assets | $15.65B |
| Total Liabilities | $11.50B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $95.00M of capital spending, operating cash flow left $236.00M of free cash flow.
| Operating Cash Flow | $331.00M |
|---|---|
| Capital Expenditures | $95.00M |
| Free Cash Flow | $236.00M |
| FCF Per Share | $4.54 |
| Depreciation and Amortization | $161.00M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 0.39%, against a 5-year average of 3.58%.
| Gross Margin | 12.60% |
|---|---|
| Operating Margin | 0.39% |
| Pretax Margin | -0.09% |
| Net Margin | -0.11% |
| EBITDA Margin | 0.75% |
| EBIT Margin | 0.39% |
| FCF Margin | 0.53% |
| Gross Margin (5Y Average) | 14.78% |
| Operating Margin (5Y Average) | 3.58% |
| Net Margin (5Y Average) | 2.40% |
Growth
Revenue grew 12.42% a year over 3 years, and EPS fell 15.91% a year.
| Revenue Growth (3Y CAGR) | +12.42% |
|---|---|
| Revenue Growth (5Y CAGR) | +18.52% |
| EPS Growth (3Y CAGR) | -15.91% |
| EPS Growth (5Y CAGR) | -5.93% |
| Operating Income Growth (3Y CAGR) | -12.68% |
| Book Value Per Share Growth (2Y CAGR) | +5.17% |
| Tangible Book Per Share Growth (2Y CAGR) | -11.89% |
Dividends and Yields
MOH does not pay a dividend. Its free cash flow yield is 2.04%.
| Earnings Yield | 0.90% |
|---|---|
| FCF Yield | 2.04% |
| Buyback Yield | 0.00% |
| Shareholder Yield | 0.00% |
Stock Splits
The last split was a 3-for-2 forward split on May 23, 2011.
| Last Split Date | May 23, 2011 |
|---|---|
| Split Type | Forward split |
| Split Ratio | 3:2 |
Peer Position
Against 12 similar companies, MOH has the 2nd highest P/E and the 11th highest P/S.
P/E RatioPeer median 16.7x
P/S RatioPeer median 0.5x
ROICPeer median 8.99%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +8.85%
| P/E Ratio | 110.7x vs 16.7x median |
|---|---|
| P/S Ratio | 0.3x vs 0.5x median |
| ROIC | 2.17% vs 8.99% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | -0.95% vs +8.85% median |
Analyst Forecast
Consensus estimates put revenue growth at 2.40% and EPS growth at -5.37% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +2.40% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | -5.37% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About MOH
What is MOH's market cap?
Molina Healthcare has a market cap of $12.17B. Its enterprise value, which adds debt and subtracts cash, is $11.46B.
What is MOH's P/E ratio?
Molina Healthcare has a trailing P/E ratio of 110.7x and a forward P/E of 41.5x.
How many shares of MOH are outstanding?
Molina Healthcare has 52.20M shares outstanding. The count is up 1.56% from a year earlier.
Does MOH pay a dividend?
No. Molina Healthcare does not pay a dividend.
How much debt does MOH have?
Molina Healthcare has $3.77B of total debt and $4.48B of cash and equivalents, a net cash position of $708.00M.
MOH pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors